Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00379444 · ClinicalTrials.gov registry record · Phase 1
Tobacco Cessation Treatment for Pregnant Alaska Natives
A Phase 1 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 1
- Development phase
- 35
- Enrollment target
NCT00379444: Completed Phase 1 study, sponsored by Mayo Clinic.
NCT00379444 is a Phase 1 study that has completed, run by Mayo Clinic. The registered enrollment target is 35 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00379444, a Phase 1 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 35 participants
- Enrollment target
Study Summary
This study will develop a culturally appropriate tobacco cessation behavioral intervention for Alaska Native women who are pregnant and who use tobacco. We will examine the feasibility of the intervention in terms of recruitment and retention of participants, acceptability to patients and prenatal health care providers, and the potential effectiveness of the tobacco use intervention.
Interventions
- BEHAVIORAL Standard intervention (counseling + self-help written materials)
- BEHAVIORAL Enhanced Intervention (same as standard treatment plus 10-15 min of counseling and a culturally tailored video)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2006-11 |
| Est. Completion | 2008-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00379444
The ClinicalTrials.gov registry entry for NCT00379444 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard intervention (counseling + self-help written materials) is the first listed.
NCT00379444 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00379444 about?
NCT00379444 is a clinical study titled "Tobacco Cessation Treatment for Pregnant Alaska Natives". This study will develop a culturally appropriate tobacco cessation behavioral intervention for Alaska Native women who are pregnant and who use tobacco. We will examine the feasibility of the intervention in terms of recruitment and retention of participants, acceptability to patients and prenatal h...
What is the current status of trial NCT00379444?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 35 participants. The study started on 2006-11. Estimated completion is 2008-11.
What interventions are being tested in trial NCT00379444?
The interventions under investigation include: Standard intervention (counseling + self-help written materials) (BEHAVIORAL), Enhanced Intervention (same as standard treatment plus 10-15 min of counseling and a culturally tailored video) (BEHAVIORAL).
Who is sponsoring clinical trial NCT00379444?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.